What is the most likely diagnosis for an adult patient with a slow-growing skull lesion, presenting with symptoms such as headaches and visual disturbances, considering their workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Diagnosis: Meningioma

For an adult patient with a slow-growing skull lesion presenting with headaches and visual disturbances, meningioma is the most likely diagnosis, representing the most common benign skull base tumor in this clinical scenario. 1

Epidemiologic Rationale

  • Meningiomas account for the majority of benign primary CNS neoplasms in adults, making them statistically the most probable diagnosis when encountering a slow-growing skull lesion 1
  • These tumors characteristically present as slow-growing masses that cause symptoms through mass effect on adjacent structures rather than through invasion 1
  • The combination of headaches and visual disturbances is classic for meningiomas affecting the skull base, particularly those in suprasellar or parasellar locations 2, 1

Clinical Presentation Pattern

  • Headaches occur commonly with skull base meningiomas and represent one of the most frequent presenting symptoms 2
  • Visual disturbances develop when meningiomas compress the optic apparatus, including the optic nerves, chiasm, or tracts, which is particularly common with skull base locations 2
  • The slow-growing nature described fits perfectly with meningioma biology, as these tumors typically expand gradually over months to years before becoming symptomatic 1, 3

Alternative Considerations in the Differential

While meningioma is most likely, the differential diagnosis for skull base lesions with these symptoms includes:

  • Schwannomas represent 3-5% of skull base tumors but typically present with hearing loss rather than visual symptoms when located in the cerebellopontine angle 2
  • Pituitary adenomas should be considered if the lesion is sellar/suprasellar, as they commonly cause visual field defects (bitemporal hemianopsia) and headaches 2
  • Skull base leiomyomas/angioleiomyomas are exceedingly rare (only 34 cases reported in literature through 2021) and should be considered only after more common entities are excluded 2
  • Chordomas are slow-growing but typically present with cranial nerve deficits and are less common than meningiomas 4

Critical Diagnostic Pitfalls to Avoid

  • Do not assume all slow-growing skull lesions are benign—while meningiomas are histologically benign, their location can cause significant morbidity and mortality through compression of vital structures 1
  • Do not delay neuroimaging with MRI brain with and without contrast, which is the gold standard for characterizing skull base masses and their relationship to critical neurovascular structures 2, 5
  • Do not overlook the need for ophthalmologic examination including formal visual field testing, as visual deficits may be subtle initially but can become irreversible if not addressed promptly 2
  • Do not confuse psychiatric symptoms (personality changes, mood disturbances) as primary psychiatric illness—meningiomas can present with isolated neuropsychiatric symptoms, particularly frontal lobe lesions 3

Recommended Diagnostic Approach

  • Obtain MRI of the brain with and without contrast as the initial imaging study, which provides superior soft tissue characterization compared to CT and defines the tumor's relationship to adjacent structures 2, 5
  • Add thin-section imaging through the skull base if the lesion involves sellar/parasellar regions to better define involvement of the cavernous sinus and optic apparatus 2, 5
  • Consider CT of the head with contrast as complementary imaging to evaluate for bone involvement, hyperostosis (characteristic of meningioma), or erosion 2
  • Arrange urgent ophthalmologic evaluation with formal visual field testing and fundoscopic examination to document baseline visual function before intervention 2

Management Implications

  • Surgical resection remains the primary treatment for symptomatic skull base meningiomas causing mass effect on critical structures 1
  • Observation with serial imaging is appropriate for small, asymptomatic meningiomas discovered incidentally, as many remain stable for years 1
  • Radiation therapy serves as adjuvant treatment for subtotally resected tumors or as primary therapy for surgically inaccessible lesions 1
  • Visual recovery is unlikely after the first postoperative month, making timely surgical intervention critical for preserving vision in cases with progressive visual deficits 5

References

Research

Common Histologically Benign Tumors of the Brain.

Continuum (Minneapolis, Minn.), 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Craniopharyngioma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended next step in managing a patient with a lytic lesion in the right inferior occipital skull, measuring approximately 2.1 cm craniocaudal, 3.2 cm transverse, and up to 2.5 cm anteroposterior (AP), with associated cortical thinning and minimal dural thickening, and a differential diagnosis including multiple myeloma, metastatic disease, and lymphoproliferative disorders, including Langerhans Cell Histiocytosis (LCH)?
What is the differential diagnosis and management of well-defined expansile lytic lesions of the sphenoid bone?
What is the recommended management approach for a 3 cm lytic lesion in the right occipital skull with stable size, hyperintense T1 and T2 signal, and moderate enhancement, in a patient with no mass effect, perilesional edema, or significant medical history?
Could a brain tumor be causing my memory issues and feelings of detachment after stopping my Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) medication?
What are the next steps for a 30-year-old patient with a newly identified lytic lesion on the skull and no significant medical history or symptoms?
How to explain advance directives to an older adult patient with metastatic pancreatic adenocarcinoma and a history of smoking?
What is the significance of a hemolytic cyst in the right ovary with an American College of Radiology (ACR) Ovarian-Adnexal Reporting and Data System (O-RADS) score of 2, indicating a benign finding, in a female of reproductive age?
What are the causes of pericarditis in patients of different age groups and demographics?
What are the red flag symptoms for a patient with gastroesophageal reflux disease (GERD) that warrant immediate medical attention?
What is the recommended management approach for a 30-year-old individual with a body mass index (BMI) of 20.1 kg/m², presenting with headache, visual disturbance, and head pain, and found to have a lytic lesion in the right occipital skull base on imaging studies?
What is the initial approach to managing an adult patient with cirrhosis of unknown etiology and no known history of liver disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.